Showing 1 - 3 results of 3 for search 'Eric S. Schaefer', query time: 0.01s Refine Results
  1. 1
    The Financial Impact of Ehlers-Danlos Syndromes on Patients in the United States in 2022

    The Financial Impact of Ehlers-Danlos Syndromes on Patients in the United States in 2022 by Jane R. Schubart, PhD, Eric W. Schaefer, MS, Susan E. Mills, MPH, Dacre R.T. Knight, MD, Chan Shen, PhD, Clair A. Francomano, MD

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC

    Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC by Armando Santoro, Garrido Pilar, Daniel S.W. Tan, Jon Zugazagoitia, Frances A. Shepherd, Alessandra Bearz, Fabrice Barlesi, Tae Min Kim, Tobias R. Overbeck, Enriqueta Felip, Can Cai, Simantini Eddy, Tracey McCulloch, Eric S. Schaefer

    Published 2024-10-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Correction: Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC

    Correction: Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC by Armando Santoro, Garrido Pilar, Daniel S.W. Tan, Jon Zugazagoitia, Frances A. Shepherd, Alessandra Bearz, Fabrice Barlesi, Tae Min Kim, Tobias R. Overbeck, Enriqueta Felip, Can Cai, Simantini Eddy, Tracey McCulloch, Eric S. Schaefer

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: